• This record comes from PubMed

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

. 2016 ; 11 (7) : e0158817. [epub] 20160708

Language English Country United States Media electronic-ecollection

Document type Journal Article

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.

See more in PubMed

Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatol Baltim Md. 2009;50: 1282–1293. 10.1002/hep.23119 PubMed DOI PMC

Blachier M, Leleu H, Peck-Radosavljevic M, Valla D-C, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58: 593–608. 10.1016/j.jhep.2012.12.005 PubMed DOI

Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis Basel Switz. 2010;28: 155–161. 10.1159/000282080 PubMed DOI

Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43: 413–427. 10.1097/01.mpg.0000239995.58388.56 PubMed DOI

Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem? J Hepatol. 2007;46: 1133–1142. 10.1016/j.jhep.2007.03.003 PubMed DOI

Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58: 1538–1544. 10.1136/gut.2008.171280 PubMed DOI PMC

Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents. Pediatrics. 2005;115: e561–e565. 10.1542/peds.2004-1832 PubMed DOI

Ko JS, Yoon JM, Yang HR, Myung JK, Kim H, Kim HR, et al. Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci. 2009;54: 2225–2230. 10.1007/s10620-009-0949-3 PubMed DOI

Suzuki D, Hashimoto E, Kaneda H, Tokushige K, Shiratori K. Liver Failure Caused by Non-Alcoholic Steatohepatitis in an Obese Young Male. J Gastroenterol Hepatol. 2005;20: 327–329. 10.1111/j.1440-1746.2005.03724.x PubMed DOI

Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114: 147–152. 10.1172/JCI22422 PubMed DOI PMC

Louet J-F, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep. 2004;6: 180–185. PubMed

Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55: 950–954. PubMed

Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97: 199–204. 10.1016/j.physbeh.2009.02.017 PubMed DOI PMC

Rosso N, Chavez-Tapia NC, Tiribelli C, Bellentani S. Translational approaches: From fatty liver to non-alcoholic steatohepatitis. World J Gastroenterol WJG. 2014;20: 9038–9049. PubMed PMC

Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2012;18: 2300–2308. 10.3748/wjg.v18.i19.2300 PubMed DOI PMC

Larter CZ, Yeh MM. Animal models of NASH: Getting both pathology and metabolic context right. J Gastroenterol Hepatol. 2008;23: 1635–1648. 10.1111/j.1440-1746.2008.05543.x PubMed DOI

Anstee QM. Animal models in nonalcoholic steatohepatitis research: utility and clinical translation. Liver Int Off J Int Assoc Study Liver. 2011;31: 440–442. 10.1111/j.1478-3231.2011.02463.x PubMed DOI

Sanches SCL, Ramalho LNZ, Augusto MJ, da Silva DM, Ramalho FS, Sanches SCL, et al. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models, Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. BioMed Res Int BioMed Res Int. 2015; 10.1155/2015/574832 PubMed DOI PMC

Machado MV, Michelotti GA, Xie G, Almeida Pereira T, de Almeida TP, Boursier J, et al. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PloS One. 2015;10: e0127991 10.1371/journal.pone.0127991 PubMed DOI PMC

Schultz Alini. Nonalcoholic Steatohepatitis: Lessons from Different Diet-induced Animal Models. J Diabetes Metab Disord Control. 2014;1.

Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature. 2012;482: 27–29. 10.1038/482027a PubMed DOI

Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, et al. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am J Physiol Gastrointest Liver Physiol. 2011;301: G1031–1043. 10.1152/ajpgi.00211.2011 PubMed DOI

Hewitt KN, Pratis K, Jones MEE, Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology. 2004;145: 1842–1848. 10.1210/en.2003-1369 PubMed DOI

Dietz WH. Critical periods in childhood for the development of obesity. Am J Clin Nutr. 1994;59: 955–959. PubMed

Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatol Baltim Md. 2010;52: 934–944. 10.1002/hep.23797 PubMed DOI PMC

Altunkaynak BZ, Altunkaynak ME. Relationship of body weight and volume of liver. A morphometrical and stereological study. Saudi Med J. 2007;28: 891–895. PubMed

Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, et al. A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. J Clin Biochem Nutr. 2008;42: 150–157. 10.3164/jcbn.2008022 PubMed DOI PMC

Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatol Baltim Md. 2011;53: 810–820. 10.1002/hep.24127 PubMed DOI PMC

Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005;41: 1313–1321. 10.1002/hep.20701 PubMed DOI

Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29: e45 PubMed PMC

López-De León A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem Off J Histochem Soc. 1985;33: 737–743. PubMed

Hodges DM, DeLong JM, Forney CF, Prange RK. Improving the thiobarbituric acid-reactive-substances assay for estimating lipid peroxidation in plant tissues containing anthocyanin and other interfering compounds. Planta. 1999;207: 604–611. 10.1007/s004250050524 PubMed DOI

Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94: 2467–2474. 10.1111/j.1572-0241.1999.01377.x PubMed DOI

Getz GS, Reardon CA. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26: 242–249. 10.1161/01.ATV.0000201071.49029.17 PubMed DOI

Lichtenstein AH, Schwab US. Relationship of dietary fat to glucose metabolism. Atherosclerosis. 2000;150: 227–243. PubMed

Escolà-Gil JC, Llaverias G, Julve J, Jauhiainen M, Méndez-González J, Blanco-Vaca F. The cholesterol content of Western diets plays a major role in the paradoxical increase in high-density lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway. Arterioscler Thromb Vasc Biol. 2011;31: 2493–2499. 10.1161/ATVBAHA.111.236075 PubMed DOI

Della Corte C, Alisi A, Saccari A, De Vito R, Vania A, Nobili V. Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health Off Publ Soc Adolesc Med. 2012;51: 305–312. 10.1016/j.jadohealth.2012.01.010 PubMed DOI

Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T, et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res Off J Jpn Soc Hepatol. 2007;37: 50–57. 10.1111/j.1872-034X.2007.00008.x PubMed DOI

Breeding Mouse [Internet]. [cited 31 March 2016]. Available: https://www.med.umich.edu/tamc/breed.html.

de Castro UGM, dos Santos RAS, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis. 2013;12: 136 10.1186/1476-511X-12-136 PubMed DOI PMC

Keyamura Y, Nagano C, Kohashi M, Niimi M, Nozako M, Koyama T, et al. Dietary cholesterol atherogenic changes in juvenile rabbits. Biol Pharm Bull. 2015;38: 785–788. 10.1248/bpb.b14-00775 PubMed DOI

Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13: 40 10.1186/1471-2431-13-40 PubMed DOI PMC

Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005;42: 641–649. 10.1002/hep.20842 PubMed DOI

Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatol Baltim Md. 2006;44: 458–465. 10.1002/hep.21262 PubMed DOI

Takahashi Y, Inui A, Fujisawa T, Takikawa H, Fukusato T. Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases. Hepatol Res Off J Jpn Soc Hepatol. 2011;41: 1066–1074. 10.1111/j.1872-034X.2011.00855.x PubMed DOI

Fu J-F, Fang Y-L, Liang L, Wang C-L, Hong F, Dong G-P. A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin. World J Gastroenterol. 2009;15: 912–918. PubMed PMC

Ganz M, Csak T, Szabo G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol WJG. 2014;20: 8525–8534. 10.3748/wjg.v20.i26.8525 PubMed DOI PMC

Pettersson US, Waldén TB, Carlsson P-O, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PloS One. 2012;7: e46057 10.1371/journal.pone.0046057 PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...